Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
5,830.00
-200.00 (-3.32%)
At close: Jan 30, 2026
-14.39% (1Y)
| Market Cap | 139.38B -15.5% |
| Revenue (ttm) | 252.20B +4.9% |
| Net Income | 2.37B -51.9% |
| EPS | 98.86 -52.1% |
| Shares Out | 23.91M |
| PE Ratio | 58.97 |
| Forward PE | n/a |
| Dividend | 50.00 (0.86%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 68,051 |
| Average Volume | 67,431 |
| Open | 6,030.00 |
| Previous Close | 6,030.00 |
| Day's Range | 5,780.00 - 6,030.00 |
| 52-Week Range | 4,755.00 - 7,160.00 |
| Beta | 0.84 |
| RSI | 49.23 |
| Earnings Date | Aug 14, 2025 |